Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells. by Sarah E Williford, Catherine J Libby, Adetokunbo Ayokanmbi, Arphaxad Otamias, Juan J Gordillo, Emily R Gordon, Sara J Cooper, Matthew Redmann, Yanjie Li, Corinne Griguer, Jianhua Zhang, Marek Napierala, Subramaniam Ananthan, Anita B Hjelmeland

Get full text